Affymetrix this week launched its Axiom Genome-Wide CHB 1 Array, which is designed to characterize the genetic basis of disease in Han Chinese populations.
To design the array, researchers at the Bio-X Center of Shanghai Jiao Tong University and Beijing's Fuwai Hospital selected content from Affy's Axiom Genomic Database as well as Han Chinese data made available through the International HapMap Project.
According to Affy, the arrays will allow researchers to "better match cases and controls within ethnic groups so they focus only on differences by disease state, not structural differences between populations." The firm is marketing the tool to customers "interested in exploring the genetic complexities underlying disease in Han Chinese populations and in populations of Chinese descent."
Asuragen this week launched Inform Thyroid, a panel of molecular markers used on fine needle aspirates of thyroid nodules to aid physicians in the management of thyroid cancer. The FNAs are analyzed on Luminex's xMap platform.